IN VIVO STUDIES OF CARDIOPROTECTION INDUCED BY VOLATILE ANAESTHETICS - EXPERIMENTAL MODEL IN RODENTS by Ordodi, V. et al.
 406 
Bulletin UASVM, Veterinary Medicine 65(1)/2008 
pISSN 1843-5270; eISSN 1843-5378 
 
 
IN VIVO STUDIES OF CARDIOPROTECTION INDUCED BY 
VOLATILE ANAESTHETICS - EXPERIMENTAL MODEL IN 
RODENTS 
 
Ordodi V.2, G. Gheorghiu2, C. HenŃia2, Nicoleta Mirică1, D. Bărglăzan1,  
Andreea Răducan1, C. Macarie2, M. Păpurică2, O. Bedreag2, F. Mic3, V. Păunescu3,  
D. Săndesc2, Danina Muntean1 
 
“Victor Babes” University of Medicine and Pharmacy Timisoara 
1Department of Pathophysiology, 2Department of Anaesthesiology and Intensive Care, 
3County Hospital of Timişoara, Romania 
2
 Eftimie Murgu Sq., 300041, Timişoara, Romania, daninamuntean@umft.ro 
 
Keywords: ischemia-reperfusion injury; cardioprotection; volatile anaesthetics; preconditioning; 
postconditioning 
 
Abstract: Myocardial ischemic/reperfusion (I/R) injury remains a major public health burden and 
cardioprotection defined as the totality of both non-pharmacological and pharmacological interventions aimed 
at preventing the reperfusion injury; still represents a stringent necessity. There is accumulating evidence that 
volatile anaesthetics induce myocardial preconditioning when given prior to ischemia and they also protect 
the heart at the very onset of reperfusion; an effect referred to as anaesthetic postconditioning. The aims of the 
present study were: (i) to develop and validate an experimental model of regional myocardial I/R injury in rat 
hearts in situ and (ii) to investigate in this model the protective effects of cardioprotection elicited by 
anesthetic pre- and postconditioning with Isoflurane and Sevoflurane. METHODS: Anaesthetized rats (n = 6-
8/group) subjected to 30 min ischemia by coronary artery ligation and 2 h reperfusion were randomly assigned 
to one of the following groups: 1) Control group (Ctrl; no other intervention); 2) Ischemic preconditioning (I-
PreC; preconditioning by three episodes of 5 min ischemia interspersed with three episodes of 10 min 
reperfusion);  3) Isoflurane preconditioning (Iso-PreC; preconditioning by three episodes of 5 min isoflurane 
2.1% interspersed with three 10 min washout episodes); 4) Isoflurane postconditioning (Iso-PostC; 5 min 
postconditioning with isoflurane 2.1% started 3 min prior to and administered for 2 min within reperfusion); 
5) Sevoflurane preconditioning (Sevo-PreC; preconditioning by two episodes of 5 min sevoflurane 2.5% 
interspersed with two 10 min washout episodes) and 6) Sevoflurane postconditioning (Sevo-PostC; 5 min 
postconditioning with sevoflurane 2.5% started 3 min prior to and administered for 2 min within reperfusion). 
RESULTS: Myocardial injury expressed as the percent of infarct to risk area ratio (I/R%) was significantly 
reduced in I-PreC (14.3 ± 6.8%) and Iso-PreC (17 ± 5.1%) and Sevo-PreC (19.5±8.5%) when compared to the 
Ctrl group (46.4±6.5%; mean ± SD; P<0.01); but no protection was found with the postconditioning 
protocols. CONCLUSIONS: We have validated an experimental model of regional ischemia that can be used 
in studies of in vivo cardioprotection. In this model anesthetic preconditioning but not postconditioning was 




Myocardial ischemia/reperfusion (I/R) injury represents a major public health burden; 
mainly associated with acute coronary syndromes and cardiac surgery. Timely coronary 
reperfusion by either thrombolysis or primary coronary artery angioplasty has nowadays 
become the established routine therapy which effectively decreases infarct size and reduces 
mortality. Despite the unequivocal beneficial effects in stopping the progression of irreversible 
damage; reperfusion is considered a double-edged sword (Braunwald & Kloner; 1985; Skyschally 
et al; 2008) as it can itself induce severe myocardial lesions which paradoxically alleviate the 
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beneficial effects of revascularization. Accordingly; adjunct mechanical and/or 
pharmacological strategies aimed at limiting cardiomyocyte death beyond reperfusion 
therapies still represent a priority for both basic and clinical cardiovascular research.  
Ischemic preconditioning (IPreC) and postconditioning (IPostC) are two 
mechanical strategies currently investigated; as major endogenous mechanisms of protection 
of the ischemic heart. IPreC was discovered more than two decades ago (Murry et al; 1986) 
and describes the ability of short periods of non-lethal ischemia alternated with reperfusion to 
protect the heart when applied before a subsequent prolonged lethal ischemia.  The more 
recently described phenomenon of myocardial IPostC (Zhao et al; 2003); defined as a series 
of brief mechanical coronary artery occlusions and reperfusions applied at the very onset of 
post-ischemic reperfusion; is able to elicit protection similar to IPreC. Anesthetic 
preconditioning (APreC) and postconditioning (APostC) refer to cardioprotection 
triggered by volatile anesthetics administered in either setting according to different protocols 
which is considered clinically more relevant than the ischemia induced one (Weber & 
Schlack; 2008).  
The aims of the present study were: (i) to develop and validate an experimental model 
of regional myocardial I/R injury in rat hearts in situ and (ii) to investigate in this model the 
protective effects of cardioprotection elicited by anesthetic pre- and postconditioning as 
compared to cardioprotection induced by the most powerful cardioprotective mechanism 
against I/R injury; ischemic preconditioning.  
 
MATERIAL AND METHODS 
 
The experimental procedures and protocols used in this study were conducted in accordance 
with the institutional and national Guide for the Care and Use of Laboratory Animals. The 
study was carried on adult rats fed ad libitum and housed at a 12 h light/dark cycle.  
 
Animal Preparation. Male Sprague–Dawley rats (300-400 g) were anaesthetized with 
xylazine (5 mg/kg) and ketamine (75 mg/kg) intraperitoneally. The rats were intubated and 
ventilated with a custom made rodent pressure controlled ventilator (inspiratory oxygen 
concentration > 90%; respiration rate 80-85 strokes/min) to maintain blood PO2; PCO2 and 
pH in the normal physiological range (AVL 995 blood gas analyzer). The right jugular vein 
was cannulated for administration of additional anesthetics (xylazine 1/3 and ketamine 2/3) as 
appropriate. The left carotid artery was dissected free for the insertion of a fluid-filled catheter 
connected to a pressure transducer (APT 300 Hugo Sachs Elektronik-Harvard Apparatus 
GmbH) to monitor arterial blood pressure. A standard limb lead II electrocardiogram (ECG) 
was recorded from subcutaneous limb leads. Both ECG and mean arterial blood pressure 
(MABP) were continuously recorded (Digidata 1440A; Axoscope 10 software; Molecular 
Devices Ltd). Rectal temperature was recorded via a precalibrated steel thermistor probe and 
core temperature was maintained at 37-38°C with the aid of a heating pad. Left-sided lateral 
thoracotomy was performed in the 4th intercostal space. The pericardium was opened and the 
heart was gently exteriorized. A 5-0 (prolene) suture was placed under the left coronary artery 
located between the base of pulmonary artery and the left atrial appendage. The ends of the 
suture were threaded through a propylene tube to form a snare. The coronary artery was 
occluded by tightening the ends of the suture by a pair of clamps. Ischemia was confirmed by 
epicardial cyanosis downstream of the occlusion. Reperfusion of the artery was initiated by 
loosening the snare and was confirmed by visualizing epicardial hyperemia. In the group of 
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sham-operated animals the ligature was left untied. Any animal that had a sustained fall of 
MABP below 70 mmHg and dysrhythmias was discarded.  
At the end of the surgical preparation; after placing the ligature; rats were allowed to 
stabilize up to 45 min according to the experimental protocols (see below). All animals 
underwent 30 minutes of ischemia and 120 minutes of reperfusion. Coronary occlusion was 
confirmed by the hemodynamic response (typical fall in MABP); the ECG aspect (ST 
elevation) and the appearance of ventricular arrhythmias after the first 8 - 10 minutes of 




Figure 1. Example of non-sustained ventricular tachycardia and systematized premature ventricular beats 
(bigeminy) recorded in min 11 of ischemia in one animal from the Ctrl group (lower panel of ECG recording). A 
hemodynamic response (severe drop of arterial pressure) accompanies dysrhythmia  (upper panel of blood 
pressure recording). 
 
Infarct Size Studies. At the end of the 2 h-reperfusion period; the animals were euthanized 
by an overdose of anesthetic. The heart was retrogradely washed in situ with 50 mL saline 
administrated via the carotid artery after performing a small cut in the right atrium. From our 
experience this step is quite important in obtaining a clear cut delineation of both areas a risk 
and  of infarction during the subsequent staining procedures. The suture around the left 
coronary artery was reoccluded and Evans blue dye (Sigma Chemicals) was injected into the 
left ventricle via the left carotid artery cannula and allowed to diffuse for approximately 1 
minute. The Evans blue solution (2% w/v) stains the non-ischaemic (non-risk) zone of the 
myocardium deep blue whilst the ischemic (risk) region of the occluded left coronary artery 
territory remains uncolored (red). This step identifies the area at risk as the red area of 
myocardium left unstained by the blue dye. Then the heart was excised; the right ventricle 
carefully removed; the left ventricle weighed and placed in a -20°C freezer. After at least an 
hour at -20°C the heart was removed from the freezer and transversely sectioned in 2 mm 
slices from apex to base. These slices were incubated in triphenyltetrazolium chloride (TTC) 
(Sigma Chemicals) solution (1% in phosphate buffer; pH 7.4) at 37°C for 25 minutes. During 
incubation the dehydrogenases in the viable tissue react with the TTC to give formazan; a 
brick-red pigment.  By contrast; the infarcted areas remain white as the dehydrogenases are 
washed out of these areas during the reperfusion period.  This step identifies the area of 
necrosis as the pale area of myocardium left unstained by the TTC. Hearts which failed to 
survive the 120 min of reperfusion were excluded from the study since a two-hour reperfusion 
period is necessary to allow adequate washout of the enzymes. After removal from the TTC 
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solution the slices were immersed for 24 h in 10% formaldehyde solution in order to delineate 
the infarcted areas more clearly while being pressed between two glass plates which were 
wedged 2mm apart and clipped together. The slices were scanned and area at risk and area of 
necrosis were determined using the Image J software. The ratio of the area of necrosis to area 
at risk defines infarct size and was expressed as percentage. 
 
Experimental protocols. Animals (n = 6-8/group) were randomly assigned to one of the 
following groups (Fig. 2): 1) Control group (Ctrl; no other intervention); 2) Ischemic 
preconditioning (I-PreC; preconditioning by three episodes of 5 min ischemia interspersed with 
three episodes of 10 min reperfusion);  3) Isoflurane preconditioning (Iso-PreC; 
preconditioning by three episodes of 5 min isoflurane 2.1% interspersed with three 10 min 
washout episodes); 4) Isoflurane postconditioning (Iso-PostC; 5 min postconditioning with 
isoflurane 2.1% started 3 min prior to and administered for 2 min within reperfusion); 5) 
Sevoflurane preconditioning (Sevo-PreC; preconditioning by two episodes of 5 min sevoflurane 
2.5% interspersed with two 10 min washout episodes) and 6) Sevoflurane postconditioning 
(Sevo-PostC; 5 min postconditioning with sevoflurane 2.5% started 3 min prior to and 





Figure 2. Outline of the experimental protocol. For explanation of abbreviations see the above text. 
 
Statistical Analysis. Data are presented as means ± SD. Difference in the relationship 
between infarct size and area at risk were evaluated by one-way ANOVA and post hoc 
Tukey’s test (Graphpad Prism v 4.0 software). A p value < 0.05 was considered to be 
statistically significant. 
RESULTS AND DISCUSSIONS 
A total of 51 animals were instrumented to obtain 44 successful experiments. Two rats 
were excluded because of technical problems during instrumentation. Three animals died 
from intractable malignant arrhythmias during the prolonged ischemia and two rats failed to 
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complete the reperfusion period. No significant differences in hemodynamic parameters 














Figure 3. Myocardial infarct size displayed as percentage of the left ventricular area at risk in: 
 Ctrl group (n=7); I-PreC (n=8); Iso-PreC (n=8); Iso-PostC (n=7); Sevo-PreC (n=8) and Sevo-PostC (n=6). 
 P < 0.01 for I-PreC; Iso-PreC; Sevo-PreC vs. Ctrl. 
 
However; decreases in mean arterial blood pressure were observed during the second 
hour of reperfusion mainly in animals subjected to the anesthetic postconditioning protocols. 
Data concerning infarct size determination are summarized in Fig. 3. 
The infarct size was 46.4 ± 6.5% in Ctrl group (n=7) and 14.3 ± 6.8% in I-PreC group 
(n=8; p<0.001) as expected since ischemic preconditioning is associated with a major 
antinecrotic effect in every tested species. Also the current results confirm previous findings 
in the in vivo rat hearts as regarding the protective effects of anesthetic preconditioning with 
both Isoflurane and Sevoflurane as infarcted to risk ratio in Iso-PreC (n=8) and Sevo-PreC 
(n=8) groups were 17.0 ± 5.2% and 19.5±8.5%; respectively (p<0.001 vs. Ctrl; p NS vs. I-
PreC). 
However; in our hands the 2 protocols of postconditioning with either Isoflurane or 
Sevoflurane were not able to elicit cardioprotection. The infarct size was significantly larger; 
37.9±8.2% and 41.8±6.0% in Iso-PostC group (n=7); and Sevo-PostC group (n=6); respectively 
(p NS vs. Ctrl). These data are intriguing since postconditioning with Sevoflurane recapitulated 
a similar protocol/dose used by Obal et al. (2005) in the same experimental setting (in vivo rat 
hearts) whereas the protocol used with Isoflurane was reproduced in the in situ rabbit heart 
(Chiari et al.; 2005) and both papers reported cardioprotective effects. Isoflurane 
postconditioning; albeit given for a longer period during the postischemic reperfusion (15 min 
and 10 min); was also reported to protect isolated perfused rat hearts (Feng et al; 2005; 
Deyhimy et al.; 2007; respectively). However; there are conflicting results concerning the 
possibility to enhance myocardial protection by combining Sevoflurane pre- and 
postconditioning according to the experimental model used: additive cardioprotection in the in 
vivo rat hearts (Obal et al.; 2005) but no additional protection in isolated hearts (Deyhimy et al; 
2007). The reason for the divergent results may be related to the different anesthetics used for 
the surgical preparation; mainly racemic ketamine in our study (vs. alpha-chloralose in the study 
by Obal et al.; 2005); which was reported to block cardioprotection triggered by experimental 
ischemic preconditioning in rabbits (Mullenheim; 2001). Even if IPC-related cardioprotection 
was not blunted in the present study; possible interferences with other anesthetics cannot be 
excluded. We are currently investigating the effects of different anesthetic regimens in the 
presence of anesthetic pre-and postconditioning protocols.  
 






























In conclusion; we have validated an experimental model that can be readily used in 
studies of in vivo cardioprotection. In this model anesthetic preconditioning; but not 
postconditioning; with either Isoflurane or Sevoflurane elicited a reduction in infarct size 
comparable to the one induced by ischemic preconditioning; the most powerful mechanism of 
endogenous protection.  
Lethal reperfusion injury was proved to be a clinical reality; accordingly;  both 
mechanistic and pharmacological research approaches in the field of reperfusion injury appear 
to be necessary and clinically relevant. However; before transferring the results obtained in a 
peculiar animal model to the clinical more complicated situation; a cautious outlook is 
warranted. Further elucidation of the mechanisms responsible for the anesthetic-related 
cardioprotection will certainly contribute to our understanding of their use in targeted clinical 
situations. 
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